LADONNA FRANKLIN: Open Payments
NPI 1184324626 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,305 in 27 payments from 8 companies in 2025. Trend: 2023 $143 · 2024 $775 · 2025 $1,305
Food & beverage: $1,305
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $714 |
| Neurocrine BioSciences, Inc. | 11 | $323 |
| Novo Nordisk Inc | 2 | $129 |
| Exact Sciences Corporation | 3 | $51 |
| Lilly USA, LLC | 1 | $27 |
| Dexcom, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: AIRSUPRA, INGREZZA, BREZTRI, Ozempic, The Cologuard Plus Collection Kit, MOUNJARO, DEXCOM G7 GSS (161), FARXIGA.
Industry payments across MD — which companies pay providers there.
